UBM Guided Site and Extent of Trabeculotomy in Pediatric Glaucoma
NCT ID: NCT05530031
Last Updated: 2022-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2022-09-30
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inverted T Trabeculectomy Primary Congenital Glaucoma
NCT06837610
Viscotrabeculotomy in Pediatric Glaucoma Following Cataract Surgery
NCT05011747
Optical Coherence Tomography of the Irido-Corneal Angle Before and After Goniotomy and Trabeculotomy in Primary Congenital Glaucoma
NCT07012252
MicrocatheterTrabeculotomy in Primary Congenital Glaucoma
NCT04116450
Visco-Circumferential-Suture-Trabeculotomy Versus Trabeculotomy
NCT04683289
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
History taking:
* Family history of ocular pathologies or syndromes.
* Age at which the mother noticed ocular affection, time and type of intervention.
* Onset of IOP elevation, IOP lowering medications used and any previous surgical intervention for glaucoma.
Preoperative examination \& assessment
* Examination under anaesthesia for state of the conjunctiva, conreal incision scars, corneal diameter, Haab's stria, broad limbus, anterior chamber depth, regularity and content, pupil shape, centration and response to mydriatics, IOL position and status in pseudophakic cases, IOP value, optic nerve cupping.
* A scan for axial length and central corneal thickness.
* B scan ultrasonography.
* UBM : full detailed anterior segment examination will be done including : trabecular iris angle width , presence of abnormal iris insertion , abnormal membranes , Schlemm canal studying and iris thickness. All these parameters will be recorded for all 4 quadrants to select the most appropriate site of trabeculotomy.
Procedure
• trabeculotomy (with Metal Trabeculotome): a scleral flap is raised at the selected site with UBM and a cutdown in shlemm's canal is performed, a metal trabeculotome is used to cannulate and tear through a section of the inner wall of SC and trabeculum into the AC. Closure of the scleral flap and conjunctiva with 10/0 nylon. Viscoelastic is used to dilate the schlemm's canal, form the anterior chamber and decrease the risk of hyphema.
Follow up
* Postoperative visits planned on the first day, first week, second week, at first month, three months and six months.
* Outcome measures included the IOP value at each visit, corneal diameters, cup disc ratio if accessible, the number of glaucoma medications used, the number and kind of complications.
* Surgical success was defined as:
1. Complete sucess when IOP \>5mmHg and ≤21mmHg or 30% IOP reduction from baseline and without any further IOP-lowering surgery.
2. Qualitative success when IOP ≤21mmHg or 30% IOP reduction from baseline but with the use of IOP lowering medications.
* Failure is defined as:
* IOP more than 21mmHg despite the use of IOP lowering medications.
* Hypotony: IOP ≤5mmHg persistent for more than two weeks.
* Need for other glaucoma surgery to control IOP.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pediatric glaucoma patients either primary or secondary
All Cases with pediatric glaucoma prepared for trabeculotomy including Primary congenital glaucoma and secondary glaucoma as : glaucoma following cataract surgery and traumatic glaucoma
trabeculotomy ( angle glaucoma surgery )
a scleral flap is raised at the selected site with UBM and a cutdown in shlemm's canal is performed, a metal trabeculotome is used to cannulate and tear through a section of the inner wall of SC and trabeculum into the AC. Closure of the scleral flap and conjunctiva with 10/0 nylon. Viscoelastic is used to dilate the schlemm's canal, form the anterior chamber and decrease the risk of hyphema.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
trabeculotomy ( angle glaucoma surgery )
a scleral flap is raised at the selected site with UBM and a cutdown in shlemm's canal is performed, a metal trabeculotome is used to cannulate and tear through a section of the inner wall of SC and trabeculum into the AC. Closure of the scleral flap and conjunctiva with 10/0 nylon. Viscoelastic is used to dilate the schlemm's canal, form the anterior chamber and decrease the risk of hyphema.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dina abdelfattah
Dina Abd Elfattah
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dina Abd Elfattah
Al Mansurah, Dakahlia Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R.22.09.1801
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.